SCHEDULE: Vanguard Amends PROCEPT BioRobotics Stake to 0% Post-Realignment
Beneficial Ownership Amendment
The Vanguard Group reported 0% beneficial ownership in PROCEPT BioRobotics Corp following an internal realignment and disaggregated reporting strategy.
Summary
- The Vanguard Group filed an Amendment No. 4 to its Schedule 13G for PROCEPT BioRobotics Corp.
- Vanguard now reports 0% beneficial ownership in PROCEPT BioRobotics Corp Common Stock.
- This change is due to an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
- Certain subsidiaries or business divisions of Vanguard will now report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538.
- These subsidiaries and/or business divisions continue to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc.
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event for PROCEPT BioRobotics Corp, as it primarily concerns an internal reporting change by The Vanguard Group rather than a direct assessment of PROCEPT's performance or prospects.
Industry Context
StockSavvy.ai notes that this filing reflects a technical reporting change by a major institutional investor, The Vanguard Group, rather than a strategic shift related to PROCEPT BioRobotics Corp's operational performance or industry position. Such internal realignments by large asset managers are not uncommon and typically do not signal a change in investment thesis for the underlying company.
Stakeholder Impact
- Minimal direct impact on PROCEPT BioRobotics Corp shareholders, as the change reflects an internal reporting adjustment by Vanguard rather than a divestment based on PROCEPT's fundamentals.
Key Dates
| Date | Description |
|---|---|
| 2026-01-12 | The Vanguard Group, Inc. underwent an internal realignment, leading to changes in beneficial ownership reporting. |
| 2026-03-13 | Date of event requiring the filing of this Schedule 13G Amendment. |
| 2026-03-27 | Date the Schedule 13G Amendment was signed by The Vanguard Group. |
Keywords
PROCEPT BioRobotics, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investor, Common Stock, 74276L105
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.